川崎病患儿血清脂联素水平的变化

黄秒; 董国庆; 蒋红英; 张纪泳; 石小娟

doi:10.7499/j.issn.1008-8830.2015.01.008

PDF(1256 KB)

HTML

中国当代儿科杂志 ›› 2015, Vol. 17 ›› Issue (1) : 35-39. DOI: 10.7499/j.issn.1008-8830.2015.01.008

论著·临床研究

川崎病患儿血清脂联素水平的变化

黄秒, 董国庆, 蒋红英, 张纪泳, 石小娟

作者信息 +

Serum adiponectin levels in children with Kawasaki disease

HUANG Miao, DONG Guo-Qing, JIANG Hong-Ying, ZHANG Ji-Yong, SHI Xiao-Juan

Author information +

文章历史 +

摘要

目的探讨川崎病(Kawasaki disease, KD)患儿血清脂联素的变化及意义.方法选取KD 患儿45 例,其中冠状动脉损伤(CAL)患儿18 例,未合并CAL 患儿27 例;另选取健康儿童20 例作为对照组.采用ELISA 法检测血清脂联素水平,全自动生化测定仪检测血脂四项,包括甘油三酯(TG)、胆固醇(TC)、低密度脂蛋白(LDL-C)、高密度脂蛋白(HDL-C).结果合并CAL 与未合并CAL 组急性期、亚急性期、恢复期血清脂联素水平均低于正常对照组(P<0.01);急性期与亚急性期其水平均低于恢复期(P<0.01).在急性期与恢复期,CAL 组血清脂联素水平显著高于未合并CAL 组(P<0.05).合并CAL 与未合并CAL 组血清TC、HDL、LDL 均较正常对照组降低(P<0.05).KD 患儿血清脂联素水平与TC、TG、CRP 水平及CAL 的发生呈明显正相关,r 分别为0.31、0.30、0.34、0.35,均P<0.05.结论 KD 患儿存在血脂紊乱及低脂联素水平;血清脂联素水平降低可能是全身炎症反应的结果;血清脂联素增加与CAL 的发生关系密切.

Abstract

Objective To explore the change in serum adiponectin levels and its significance in children with Kawasaki disease (KD). Methods Forty-five KD patients were enrolled in this study, including 18 with coronary artery lesions (CAL group) and 27 without coronary artery lesions (NCAL group). Twenty healthy children were recruited to the control group. Enzyme-linked immunosorbent assay was used to measure serum adiponectin levels, and an automatic biochemical analyzer was used to measure the levels of triglyceride (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C). Results The serum adiponectin levels in the CAL and NCAL groups were significantly lower than in the control group during the acute phase, subacute phase, and recovery phase (P<0.01), with lower levels observed during the acute phase and subacute phase (P<0.01). Compared with the NCAL group, the CAL group had significantly higher serum levels of adiponectin during the acute phase and recovery phase (P<0.05). The levels of TC, HDL, and LDL in the NCAL and CAL groups were significantly lower than in the control group (P<0.05). The levels of serum adiponectin in KD patients were positively correlated with the levels of TC, TG, and C-reactive protein and the occurrence of CAL (r=0.31, 0.30, 0.34, and 0.35, respectively; P<0.05). Conclusions Children with KD have metabolic disorders of blood lipids and reduced serum adiponectin levels. Reduced serum adiponectin levels may be the result of systemic inflammation, while increased adiponectin levels may be closely associated with the occurrence of CAL.

导出引用

黄秒, 董国庆, 蒋红英, 张纪泳, 石小娟. 川崎病患儿血清脂联素水平的变化[J]. 中国当代儿科杂志. 2015, 17(1): 35-39 https://doi.org/10.7499/j.issn.1008-8830.2015.01.008

HUANG Miao, DONG Guo-Qing, JIANG Hong-Ying, ZHANG Ji-Yong, SHI Xiao-Juan. Serum adiponectin levels in children with Kawasaki disease[J]. Chinese Journal of Contemporary Pediatrics. 2015, 17(1): 35-39 https://doi.org/10.7499/j.issn.1008-8830.2015.01.008

参考文献

[1] Takeshita S, Takabayashi H, Yoshida N. Circulating adiponectin levels in Kawasaki disease[J]. Acta Paediatr, 2006, 95(10): 1312-1314.
[2] Ayusawa M, Sonobe T, Uemura S, et al. Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition)[J]. Pediatr Int, 2005, 47(2): 232-234.
[3] 胡亚美, 江载芳. 诸福棠实用儿科学[M]. 北京: 人民卫生出版社, 2002: 698-705.
[4] Scherer PE, Williams S, Fogliano M, et al. A novel serum protein similar to C1q, produced exclusively in adipocytes[J]. J Biol Chem, 1995, 270(45): 26746-26749.
[5] Furukawa S, Matsubara T, Ichiyama T. Regulation of proinflammatory cytokine cascade in Kawasaki disease[J]. Nihon Rinsho, 2008, 66(2): 258-264.
[6] Simons PJ, van den Pangaart PS, Aerts JM, et al. Proinflammatory delipidizing cytokines reduce adiponectin secretion from human adipocytes without affecting adiponectin oligomerization[J]. J Endocrinol, 2007, 192: 289-299.
[7] Iwaki M, Matsuda M, Maeda N, et al. Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors[J]. Diabetes, 2003, 52(7): 1655-1663.
[8] Ruan Y, Ye B, Zhao X. Clinical characteristics of Kawasaki syndrome and the risk factors for coronary artery lesions in China[J]. Pediatr Infect Dis J, 2013, 32(10): e397-e402.
[9] Akbiyik F, Ray DM, Gettings KF, et al. Human bone marrow megakaryocytes and platelets express PPARgamma, and PPARgamma agonists blunt platelet release of CD40 ligand and thromboxanes[J]. Blood, 2004, 104(5): 1361-1368.
[10] Cabana VG, Gidding SS, Getz GS, et al. Serum amyloid A and high density lipoprotein participate in the acute phase response of Kawasaki disease[J]. Pediatr Res, 1997, 42(5): 651-655.
[11] Naderali EK, Estadella D, Rocha M, et al. A fat-enriched, glucose-enriched diet markedly attenuates adiponectin mRNA levels in rat epididymal adipose tissue[J]. Clin Sci(Lond), 2003, 105(4): 403-408.
[12] Suriyaprom K, Phonrat B, Namjuntra P, et a1. The-11377> G adiponectin gene polymorphism alters the adiponectin concentration and the susceptibility to type 2 diabetes in Thais[J]. Int J Vitam Nutr R, 2010, 80(3): 216-224.
[13] Takaoka M, Suzuki H, Shioda S, et al. Endovascular injury induces rapid phenotypic changes in perivascular adipose tissue[J]. Arterioscler Thromb Vasc Biol, 2010, 30(8): 1576-1582.
[14] Aghamohammadzadeh R, Withers S, Lynch F, et al. Perivascular adipose tissue from human systemic and coronary vessels: the emergence of a new pharmacotherapeutic target[J]. Br J Pharmacol, 2012, 165(3): 670-682.
[15] Yu X, Hirono KI, Ichida F, et al. Enhanced iNOS expression in leukocytes and circulating endothelial cells is associated with the progression of coronary artery lesions in acute Kawasaki disease[J]. Pediatr Res, 2004, 55(4): 688-694.
[16] Fukazawa R, Ikegam E, Watanabe M, et al. Coronary artery aneurysm induced by Kawasaki disease in children show features typical senescence[J]. Circ J, 2007, 71(5): 709-715.
[17] Addabbo F, Nacci C, De Benedictis L, et al. Globular adiponectin counteracts VCAM-1-mediated monocyte adhesion via AdipoR1/NF-kappaB/COX-2 signaling in human aortic endothelial cells[J]. Am J Physiol Endocrinol Metab, 2011, 301(6): E1143-E1154.
[18] Mantzoros CS, Li T, Manson JE, et al. Circulating adiponectin levels are associated with better glycemic control, more favorable lipid profile, and reduced inflammation in women with type 2 diabetes[J]. Clin Endocrinol Metab, 2005, 90(8): 4542-4528.
[19] Yamauchi T, Kamon J, Minokoshi, et al. Adiponection stimulates glucose atilizationandfatty-acidoxidation by activating AMPactivated protein kinase[J]. Nature Med, 2002, 8(11): 1288-1295.
[20] 张园海, 陆文文, 陈其, 等. 川崎病患儿血脂代谢变化的检测及分析[J]. 中国实用儿科杂志, 2004, 9(5): 303.
[21] 王献民, 李焰, 柳颐龄. 川崎病患儿并发冠状动脉病变的危险因素分析[J]. 中国当代儿科杂志, 2012, 14(12): 938-941.
[22] Ashouri N, Takahashi M, Dorey F, et al. Risk factors for nonresponse to therapy in Kawasaki disease[J]. J Pediatr, 2008, 153(3): 365-368.
[23] Ou CY, Tseng YF, Lee CL, et al. Significant relationship between serum high-sensitivity C-reactive protein, high-density lipoprotein cholesterol levels and children with Kawasaki disease and coronary artery lesions[J]. Formos Med Assoc, 2009, 108(9): 719-724.
[24] Ouchi N, Kihara S, Funahashi T, et al. Obesity, adiponectin and vascular inflammatory disease[J]. Curr Opin Lipidol, 2003, 14(6): 561-566.
[25] Honkanen VE, Mccrindle BW, Laxer RM, et al. Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease[J]. Pediatr Cardiol, 2003, 24(2): 122-126.
[26] Kemmotsu Y, Saji T, Kusunoki N, et al. Serum adipokine profiles in Kawasaki disease[J]. Mod Rheumatol, 2012, 22(1): 66-72.